An Open-label Study to Evaluate the Pharmacokinetics and Safety of Bimekizumab in Pediatric Study Participants With Active Juvenile Idiopathic Arthritis Subtypes Enthesitis-related Arthritis (Including Juvenile-onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis

RECRUITING

Ja0005 50646, Calgary

RECRUITING

Ja0005 50644, Montreal

RECRUITING

Ja0005 50645, Saskatoon

RECRUITING

Ja0005 40777, Indre-et-Loire

RECRUITING

Ja0005 40510, Le Kremlin-Bicêtre

RECRUITING

Ja0005 40778, Paris

RECRUITING

Ja0005 40776, Poitiers

RECRUITING

Ja0005 40369, Berlin

RECRUITING

Ja0005 40356, Dresden

ACTIVE_NOT_RECRUITING

Ja0005 40072, Freiburg im Breisgau

RECRUITING

Ja0005 40852, Hamburg

RECRUITING

Ja0005 40787, Sankt Augustin

ACTIVE_NOT_RECRUITING

Ja0005 40779, Sendenhorst

RECRUITING

Ja0005 40427, Tübingen

RECRUITING

Ja0005 40720, Krakow

ACTIVE_NOT_RECRUITING

Ja0005 40780, Sosnowiec

RECRUITING

Ja0005 40781, Esplugues de Llobregat

RECRUITING

Ja0005 40100, Madrid

RECRUITING

Ja0005 40782, Valencia

ACTIVE_NOT_RECRUITING

Ja0005 40786, Bristol

RECRUITING

Ja0005 40783, Manchester

RECRUITING

Ja0005 40785, Nottingham

ACTIVE_NOT_RECRUITING

Ja0005 40784, Stroke-on-trent